Growth Metrics

Eli Lilly (LLY) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 43.66%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 11.49%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 8.59%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 3,250.86%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 22.98%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 4.00%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 5.75%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 6.17%
10 Gsk 88.34 Bn 83.66 Bn - 4.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 43.66%
Dec 31, 2025 44.28%
Sep 30, 2025 37.99%
Jun 30, 2025 38.44%
Mar 31, 2025 35.60%
Dec 31, 2024 32.43%
Sep 30, 2024 36.32%
Jun 30, 2024 31.50%
Mar 31, 2024 29.18%
Dec 31, 2023 27.30%
Sep 30, 2023 27.41%
Jun 30, 2023 23.54%
Mar 31, 2023 15.86%
Dec 31, 2022 12.90%
Sep 30, 2022 4.38%
Jun 30, 2022 3.08%
Mar 31, 2022 5.48%
Dec 31, 2021 3.49%
Sep 30, 2021 7.72%
Jun 30, 2021 10.96%
Mar 31, 2021 9.27%
Dec 31, 2020 10.28%
Sep 30, 2020 6.15%
Jun 30, 2020 1.70%
Mar 31, 2020 1.52%
Dec 31, 2019 -1.54%
Sep 30, 2019 -11.49%
Jun 30, 2019 -10.53%
Mar 31, 2019 -13.15%
Dec 31, 2018 -9.41%
Sep 30, 2018 2.51%
Jun 30, 2018 2.19%
Mar 31, 2018 6.32%
Dec 31, 2017 6.95%
Sep 30, 2017 4.20%
Jun 30, 2017 6.41%
Mar 31, 2017 4.88%
Dec 31, 2016 2.47%
Sep 30, 2016 2.19%
Jun 30, 2016 0.54%
Mar 31, 2016 1.04%
Dec 31, 2015 1.13%
Sep 30, 2015 0.40%
Jun 30, 2015 -0.97%
Mar 31, 2015 -0.25%
Dec 31, 2014 -0.15%
Sep 30, 2014 3.55%
Jun 30, 2014 6.08%
Mar 31, 2014 4.56%
Dec 31, 2013 2.77%
Sep 30, 2013 1.68%
Jun 30, 2013 0.22%
Mar 31, 2013 -1.69%
Dec 31, 2012 0.00%
Sep 30, 2012 -2.22%
Jun 30, 2012 -4.20%
Mar 31, 2012 -2.67%
Dec 31, 2011 -2.27%
Sep 30, 2011 -1.63%
Jun 30, 2011 2.17%
Mar 31, 2011 -0.24%
Dec 31, 2010 -3.13%
Jun 30, 2010 -9.42%